The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression

Dobos, N., de Vries, E. F. J., Kema, I. P., Patas, K., Prins, M., Nijholt, I. M., Dierckx, R. A., Korf, J., den Boer, J. A., Luiten, P. G. M. & Eisel, U. L. M., 2015, Handbook of Depression in Alzheimer's Disease. Smith, G. S. (ed.). IOS Press, Vol. 4. p. 163-173 11 p. (Advances in Alzheimer's Disease; vol. 4).

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

Indoleamine 2,3-dioxygenase (IDO), an enzyme which is activated by pro-inflammatory cytokines, has been suggested as a potential link between neuroinflammatory processes in neurodegenerative diseases (like Alzheimer's disease) and depression. The present study aimed to determine whether neuroinflammation-induced increased IDO levels in the mammalian brain will lead to depressive-like behavior. Neuroinflammation was initiated in mice by a single intracerebroventricular injection of lipopolysaccharide (LPS). Cerebral inflammation was monitored 1, 2, 3 and 4 days after the injection with small-animal positron emission tomography (PET) using the inflammatory marker [11C]-PK11195. In the presence or absence of systemically applied 1-methyl-tryptophan (1-MT), a competitive IDO-inhibitor, we assessed the development of depressive-like behavioral symptoms in parallel with IDO expression and activity. The PK11195 PET signal reached a highly significant peak 3 days after LPS injection, while these animals displayed a significant increase of depressive-like behavior in the forced swim test compared to vehicle-injected animals. These findings were paralleled by a significant increase of IDO in the brainstem, and an increased kynurenine/tryptophan ratio in the serum. Moreover, we report here for the first time, that inhibition of IDO by 1-MT in centrally induced neuroinflammation under experimental conditions can prevent the development of depressive-like behavior.

Original languageEnglish
Title of host publicationHandbook of Depression in Alzheimer's Disease
EditorsGwenn S. Smith
PublisherIOS Press
Number of pages11
ISBN (Electronic)9781614995418
Publication statusPublished - 2015

Publication series

NameAdvances in Alzheimer's Disease
ISSN (Print)22105727
ISSN (Electronic)22105735


  • Depression, Indoleamine 2,3-dioxygenase, Lipopolysaccharide, Neuroinflammation, Positron emission tomography

ID: 40518555